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It was recently demonstrated that the rat-selective toxicant norbormide also induces rat-selective opening of the permeability transition pore
(PTP) in isolated mitochondria. Norbormide is a mixture of endo and exo stereoisomers; however, only the endo forms are lethal to rats. In the
present study we tested both endo and exo isomers as well as neutral and cationic derivatives of norbormide to: (i) verify if the PTP-regulatory
activity by norbormide is stereospecific; (ii) define the structural features of norbormide responsible for PTP-activation, (iii) elucidate the basis for
the drug species-specificity. Our results show that: (i) norbormide isomers affect PTP in a rat-selective fashion; however, no relevant differences
between lethal and non-lethal forms are observed suggesting that drug regulation of PTP-activity and lethality in rats are unrelated phenomena; (ii)
a (phenylvinyl)pyridine moiety represents the key element conferring the PTP-activating effect; (iii) cationic derivatives of rat-active compounds
accumulate in the matrix via the membrane potential and activate the PTP also in mouse and guinea pig mitochondria. These findings suggest that
the norbormide-sensitive PTP-target is present in all species examined, and is presumably located on the matrix side. The species-selectivity may
depend on the unique properties of a transport system allowing drug internalisation in rat mitochondria.
© 2007 Elsevier B.V. All rights reserved.Keywords: Norbormide; Rat-toxicant; Mitochondria; Permeability transition; Species-specificity1. Introduction
Norbormide[5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyri-
dylbenzylidene)-5-norbornene-2,3-dicarboximide] (NRB) is a
toxic compound endowed with unique species-selective vaso-
constrictor activity that is restricted to the peripheral vessels of
the rat [1–6]. NRB is a mixture of eight racemic stereoisomers,
which strongly differ in their vasoconstrictor activity and
toxicity [7–9]. Investigations carried out in vitro and in vivo
on the individual isomers of NRB demonstrated that the toxic⁎ Corresponding author. C.N.R. Institute of Biomedical Technologies/Padova
Unit, Department of Biology, University of Padova, Viale Giuseppe Colombo 3,
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E-mail address: rchielli@mail.bio.unipd.it (F. Ricchelli).
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doi:10.1016/j.bbabio.2007.04.002effects of the parent compound are strongly stereospecific.
Indeed, only the endo isomers of NRB retain the rat-selective
vasoconstrictor and toxic activity elicited by the mixture [9]. The
mechanisms of NRB action have yet to be clarified but available
evidence suggests that the vasoconstrictor effect may be
mediated by the stimulation of a number of signal transduction
pathways that lead to modulation of calcium influx, presumably
mediated by phospholipase C (PLC)-coupled receptors
expressed in rat peripheral vascular myocytes [5].
Earlier studies demonstrated that in isolated mitochondria
NRB also causes rat-selective dysfunction [10] that could be
traced to the opening of the inner membrane permeability tran-
sition (PT) pore (PTP) [11], a proteinaceous channel involved in
several forms of cell death [12]. It was suggested that NRB
activates the PT through a transport system unique to the rat that
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membranes. This putative carrier was postulated to be absent in
other species, or shielded from contact with the drug owing to
different membrane structural arrangements [11].
The present paper was aimed at investigating whether the
species-specific PTP modulation and toxicity are causally
linked, and at defining the structural determinants of the effects
of NRB on the PTP. To address these questions, we studied the
PTP-regulatory properties of both vasoconstrictor and non-
vasoconstrictor NRB isomers by following the Ca2+ retention
capacity (a very sensitive method to detect PTP opening) in
isolated rat, mouse and guinea pig liver mitochondria. In
addition, a series of NRB analogues derived from the
“deconstruction” of the parent molecule was evaluated in
order to assess the structural features responsible for PTP
activation. The mechanism of NRB action was further
investigated by carrying out studies with cationic derivatives
of the drug, which should accumulate in mitochondria driven by
the inside-negative membrane potential.
Our results show that (i) there may be no direct link between
NRB-induced mitochondrial dysfunction and lethal vasocon-
striction in rats; (ii) the (phenylvinyl)pyridine subunit at C-7 is
the key element conferring the PTP-activating effects to the
NRB molecule; and (iii) NRB as well as its active core interacts
poorly with guinea pig and mouse mitochondria unless the drug
molecule is positively charged, thus allowing matrix accumu-
lation via membrane potential and subsequent triggering of the
PT. This latter finding indicates that the NRB-sensitive, PTP-
reactive site is present in all animal species, and that the species-
selectivity towards the PT depends on the unique properties of a
transport system, which facilitates drug internalisation in rat
mitochondria. Part of this work has been presented in Abstract
Form at the 14th EBEC, Moscow, 22–27 July 2006 [13].
2. Materials and methods
Norbormide (NRB) was a generous gift of I.N.D.I.A. Industria Chimica,
Padova (Italy).All isolated NRB isomers [7,8] and the following NRB analogues
[14] were prepared as previously described: endo-7-(α-2-pyridylbenzylidene)-
5-norbornene-2,3-dicarboximide (DR085), 2-(1-phenylvinyl)pyridine (DR166),
2-(1-phenyl-2-ethanol)pyridine (DR282), 5-(α-hydroxy-α-2-pyridylbenzyl)-7-
(α-phenylbenzylidene)-5-norbornene-2,3-dicarboximide (DR488) and 5-(α-
hydroxy-α-2-pyridylbenzyl)-5-norbornene-2,3-dicarboximide (DR496).
Norbornene-2,3-dicarboximide (DR067), endo-7-(α-2-phenylbenzyli-
dene)-5-norbornene-2,3-dicarboximide (DR068), 2-benzylpyridine
(DR303) and 2-(1-phenylethyl)pyridine (DR322) as well as the cationic
derivatives: N-ethyl-2-(1-phenylvinyl)pyridinium trifluoromethanesulfonate
(DR380),5-(α-hydroxy-α-2-pyridylbenzyl)-7-(N-pivaloyloxymethyl-α-2-
pyridiniumbenzylidene)-5-norbornene-2,3-dicarboximide iodide (OL14),
N-pivaloyloxymethyl-2-(1-phenylvinyl) pyridinium iodide (JS023) and N-
pivaloyloxymethyl-2-(1-phenyl-2-ethanol)pyridinium iodide (DR656) were
synthesized by Rennison, D., Laita, O., and Stäb J. (unpublished data ).
1,1-Diphenylethylene (DR598) was obtained commercially (Aldrich).
Liver mitochondria from albino Wistar rats, CD1 mice and albino guinea
pigs were prepared by standard differential centrifugation. The final pellet was
suspended in 0.25 M sucrose to give a protein concentration of 80–100 mg/ml,
as measured by the biuret method.
Mitochondrial oxygen consumption was measured in a thermostated (T=25
°C), water-jacketed vessel, using a Clark electrode connected to a recorder.
Mitochondrial PT was induced at 25 °C in a medium containing 200 mM
sucrose, 10 mM Tris–Mops, 10 μM EGTA–Tris, 1 mM Pi, 0.5 μg/mloligomycin, 5 mM succinate, 2 μM rotenone, pH 7.4 (standard medium) [15].
Ca2+ was used as PT inducer.
Extramitochondrial Ca2+ was measured fluorimetrically using Calcium
Green-5 N, a membrane impermeant probe, which exhibits an increase in
fluorescence emission intensity upon Ca2+ binding (excitation–emission λ:
480–530 nm).
Mitochondrial membrane potential (ΔΨm) changes were followed based
on the accumulation of pyronin G (Pyr G; 3 μM) as monitored by the
changes in emission fluorescence intensity at λ=580 nm (excitation
λ=520 nm) [16].
Fluidity changes of mitochondrial membranes promoted by NRB and NRB
analogues were evaluated by the changes in fluorescence anisotropy of 1,6-phenyl-
1,3,5-hexatriene (DPH) and 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-
hexatriene p-toluene sulfonate (TMA- DPH), which bind internal hydrophobic
and polar heads/lipid backbone interfaces of the membrane lipid bilayer,
respectively [17]. DPH- and TMA-DPH-labelled mitochondria were prepared by
treating mitochondrial suspensions (20 mg/ml) with 300 μM probe. After 20 min
(DPH) or 5 min (TMA-DPH) incubation under continuous stirring at T=25 °C, the
mitochondrial suspensionswere diluted to 0.2mg/ml for anisotropymeasurements.
The fluorescence anisotropy (r) was collected at 340 nm (λem=460 nm) (for DPH)
and 360 nm (λem=430 nm) (for TMA-DPH) by calculating the IVVand IVH, i.e. the
fluorescence intensities polarized parallel and perpendicular to the vertical plane of
polarization of the excitation beam respectively. The anisotropy (r) is defined by the
equation r=(IVV−GIVH) / (IVV+2GIVH), where G= IHV/IHH is the correction
factor for instrumental artefacts.
3. Results
NRB is a mixture of eight possible stereoisomers each of
which is a racemate (see the configurations below). Since the S
and U isomers are present in trace amounts, only the six most
abundant isomers (V, Y, W, R, T, X) were tested for their PT-
inducing activity on isolated mitochondria. Among them, only
the endo-isomers V, Y, and W induce vasoconstriction and
death in rats whereas the exo-forms R, T and X are ineffective
[7–9].
PTP activation was tested by measuring the calcium
retention capacity (CRC) of mitochondria, as detected by the
fluorescence changes of the Ca2+ indicator, Calcium Green 5N,
after 5 min incubation with the different NRB isomers (see Ref.
[11]).
Fig. 1 shows the effects of 50 μM isomer V and X (as
representative of the lethal and non lethal species, respectively)
on the CRC of rat liver mitochondria. Untreated mitochondria
Fig. 1. Effects of the isomers X and V of NRB on the CRC of rat liver
mitochondria. The experiments were started by the addition of 1 mg/ml
mitochondria (not shown) to the standard incubation medium. Rat liver
mitochondria were loaded with a train of 10 μM Ca2+ pulses at 1-min
intervals. Mitochondria were pre-incubated for 5 min without (control) or
with 50 μM X or V before addition of Ca2+. Extramitochondrial Ca2+ was
monitored as the fluorescence emission intensity of 0.5 μM Calcium Green-
5 N (λexcitation =480 nm; λemission =530 nm).
Fig. 2. CRC of rat, mouse and guinea pig liver mitochondria in the presence
of the NRB isomers V, Y, W, R, X, T at 10 and 50 μM. The CRC was
calculated according to the experimental procedure described in the legend
to Fig. 1. Data are expressed as mean (±SD) of three independent deter-
minations. Statistical analysis indicated that the data for rat mitochondria
incubated with NRB and NRB isomers are significantly different from
those of the controls (unpaired t-test, Pb0.01).
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intervals. Each Ca2+ addition gave rise to rapid increases of the
Calcium Green 5 N fluorescence, followed by a return to the
original steady-state value as Ca2+ was taken up by mitochon-
dria. When the loading threshold of about 120 nmol of Ca2+/mg
protein was reached, a net release of Ca2+ into the medium was
observed. Incubation with 50 μM NRB isomers V and X for
5 min decreased the Ca2+ load required for PTP opening to 70
and 50 nmol of Ca2+/mg protein, respectively. In all cases, the
addition of 1 μM cyclosporin A doubled the CRC, indicating
that Ca2+ release was due to opening of the PTP (data not
shown). Dose–response tests indicated that all NRB isomers
decreased the CRC of rat mitochondria in the concentration
range 5–100 μM, the maximal effect being reached at
approximately 40 μM (data not shown).
Fig. 2 compares the effects of low (10 μM) and high (50 μM)
concentrations of the NRB mixture and of the individual
isomers on the CRC in rat, mouse and guinea pig mitochondria.Clearly, all isomers were rat-selective in inducing the
mitochondrial PT, and all were effective at relatively low
concentrations. Importantly, no significant difference could be
detected between toxic (V, Y, W) and non toxic (R, X, T)
isomers.
In order to better define the key structural features of NRB
responsible for PTP activation in rat mitochondria, we evaluated
several related analogues, synthesized on the basis of a selected
“deconstruction” of the parent molecule (Table 1). Table 1 also
shows the structure–function correlation for the PT-inducing
effects on rat mitochondria as deduced from the values of CRC,
expressed as percent of the control (CRC of untreated
mitochondria). Substructures DR282 and DR067 exhibited
marginal effects (around 20% of CRC loss), both as
independent units or when combined in analogue DR496
(both in endo or exo configurations). Analogue DR085 was
nearly as active as the NRB mixture while DR166 displayed the
highest PT-inducing effect. All NRB substructures tested were
found to have a negligible effect on mitochondria from guinea
pig and mouse (Table 1).
The next set of experiments was aimed at investigating
whether changes in the chemical structure of the most active
compounds (NRB, DR085 and DR166) influenced their
activity in rat mitochondria. To this purpose, we analyzed
their analogues DR488, DR068 and DR598, in which the C-7
pyridyl ring was replaced by a phenyl ring, along with
Table 2
CRC of rat, mouse and guinea pig liver mitochondria in the presence of NRB
and of the substructures: DR488, DR085, DR068, DR166, DR598, DR303,
DR322
CRC (% of the control)
Structure Compound Rat Mouse Guinea pig
NRB 50±10 100±5 100±10
DR488 80±5 90±10 90±10
DR085 55±5 90±5 90±10
DR068 85±10 85±10 85±5
DR166 35±5 90±10 90±5
DR598 85±10 90±10 95±10
DR322 70±5 100±5 75±5
DR303 85±10 100±5 90±10
The Ca2+ retention capacity (expressed as % of the control) was calculated
according to the experimental procedure described in the legend to Fig. 1. Drug
concentration was 50 μM. Data are expressed as mean (±SD) of four
independent determinations.
Table 1
CRC of rat, mouse and guinea pig liver mitochondria in the presence of NRB
and of the substructures: DR282, DR067, DR496(endo), DR496(exo), DR085,
DR166
CRC (% of the control)
Structure Compound Rat Mouse Guinea pig
DR282 80±10 90±10 85±5
DR067 85±10 100±5 100±5
DR496 endo 80±20 85±10 90±10
DR496 exo 90±10 85±20 90±10
DR166 35±5 90±10 90±5
DR085 55±5 90±5 90±10
NRB 50±10 100±5 100±10
The Ca2+ retention capacity (expressed as % of the control) was calculated
according to the experimental procedure described in the legend to Fig. 1. Drug
concentration was 50 μM. Data are expressed as mean (±SD) of four
independent determinations.
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was removed (DR303) or replaced by a methyl group
(DR322).
Table 2 reports the comparison between the CRC values of
the modified analogues and the corresponding original
molecules. Chemical modifications to the original structuresof the active compounds markedly reduced their PT-inducing
activity. Thus, both the C-7 pyridyl N-atom and the terminal
methylene group were important in conferring high PTP
activation potential to the NRB molecule. Such modified
NRB analogues were also ineffective in guinea pig and mouse
mitochondria (Table 2).
We next carried out a set of experiments with cationic
derivatives of NRB, which should accumulate inside the
mitochondria driven by the transmembrane potential (negative
inside) of the inner membrane. The following cationic
analogues (OL14, JS023, DR380) based on the most active
compounds (NRB and DR166) towards the PTwere considered
together with a cationic derivative (DR656) of the inactive
analogue DR282.
Fig. 3 shows the CRC of rat mitochondria obtained in the
presence of the selected cationic drugs at 50 μM concentration,
Fig. 5. Dependence of PyrG fluorescence on the mitochondrial membrane
potential in the presence of cationic NRB derivatives (100 μM). Rat liver
mitochondria (1 mg/ml), incubated with 3 μM Pyr G, were suspended in the
standard medium in the absence of an energizing substrate. Pyr G fluorescence
(in arbitrary units) was followed by exciting at 520 nm (emission=580 nm).
Where indicated (arrows), succinate (5 mM), OL14 (trace a), JS023 (trace b),
DR380 (trace c), DR656 (trace d) or CaCl2 (10 μM) was added.
Fig. 3. Comparison between the CRC of rat liver mitochondria loaded with the
cationic compounds: OL14, JS023, DR380, and DR656 and their neutral
analogues: NRB, DR166, and DR282. The concentration of all NRB derivatives
was 50 μM. The CRC was calculated according to the experimental procedure
described in the legend to Fig. 1. Data are expressed as mean (±SD) of three
independent determinations. Statistical analysis indicated that the data obtained
in the presence of NRB, DR166, OL14, JS023, DR380 are significantly different
from those of the control (unpaired t-test, Pb0.01).
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corresponding neutral analogues. Clearly, the cationic deriva-
tives of both the parent NRB molecule and of DR166 were
much more effective in stimulating the PT. Indeed, the Ca2+
accumulated and retained before occurrence of the PT decreased
from 40–60 nmol/mg to 10–30 nmol/mg. The cationic drugs
bearing a N-pivaloyloxymethyl group (JS023 and OL14)
displayed higher PT-inducing efficacy than displayed by the
compound bearing a N-ethyl group (DR380), possibly as a
consequence of a higher degree of lipophilicity. On the contrary,Fig. 4. CRC of rat liver mitochondria loaded with increasing concentrations of
JS023, DR166 and NRB. The CRC was calculated according to the
experimental procedure described in the legend to Fig. 1. Data are expressed
as mean (±SD) of three independent determinations.no significant changes in CRC were observed after insertion of a
positive charge into DR282, thus confirming that this moiety
does not affect the PT. The dramatic increase in PT-inducing
potency of the most active compounds after addition of aFig. 6. CRC of rat and mouse liver mitochondria in the presence of increasing
concentrations of JS023 (A) and OL14 (B). The CRC was calculated according
to the experimental procedure described in the legend to Fig. 1. CRC values are
expressed as percentage of the corresponding controls (untreated mitochondria).
Data are means (±SD) of three independent determinations. Results similar to
those of mouse were obtained for guinea pig liver mitochondria.
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data of Fig. 4, which compares, as an example, the CRC values
of mitochondria supplemented with the cationic active “core”
(JS023), with its neutral analogue (DR166) and with the parent
molecule (NRB) (Fig. 4).
All the selected cationic NRB derivatives accumulated into
the mitochondrial matrix, as tested by measuring the inner
membrane potential through the fluorescence changes of Pyr G.
As shown in Fig. 5, addition of succinate to rat liver
mitochondria initiated a process of fluorescence quenching of
Pyr G, which was due to accumulation of the probe inside
energized mitochondria. Addition of the cations (C+, 100 μM)
OL14 (trace a), JS023 (trace b), DR380 (trace c) or DR656
(trace d) caused a cycle of probe release-reuptake, which
indicates a transient membrane depolarization due to cation
transport into the mitochondrial matrix. Addition of a small
pulse of Ca2+ caused collapse of the membrane potential in
mitochondria treated with OL14, JS023 and DR380. TheFig. 7. Effects of NRB, DR166 and JS023 on the fluorescence anisotropy of DPH-
labelled mitochondria were prepared by treating mitochondrial suspensions (20 mg/
under continuous stirring at T=25 °C, the mitochondrial suspensions were diluted to
collected at 340 nm (λem=460 nm) (for DPH) and 360 nm (λem=430 nm) (for TMA
addition of 50 μM NRB (A, A'), DR166 (B, B'), JS023 (C, C') (for rat mitochondria
mouse mitochondria the corresponding r°s were: 0.16±0.02 and 0.1±0.02).collapse of membrane potential was not due to the addition of
Ca2+ per se (e.g., trace d) but rather to PTP opening, as
confirmed by the effect of CsA, which prevented the Ca2+-
dependent fluorescence increase (not shown). In contrast, only a
transient depolarization due to Ca2+ transport in the matrix was
observed with DR656. Similar results were obtained for mouse
and guinea pig mitochondria (results not shown).
The availability of active cationic derivatives which
accumulate in the matrix provides a unique opportunity to test
whether the lack of effects of NRB in mouse and guinea pig
mitochondria depends on species-specific differences in PTP
structure or rather in drug transport. We therefore compared the
effects of JS023 (Fig. 6A) and OL14 (Fig. 6B) on the PT of rat
and mouse mitochondria. Strikingly, both cationic drugs were
able to induce opening of the PTP also in mouse mitochondria,
although higher concentrations were necessary to obtain effects
similar to those observed in rat mitochondria. Similar results
were observed with guinea pig mitochondria (not shown)., and TMA-DPH-labelled rat and mouse mitochondria. DPH- and TMA-DPH-
ml) with 300 μM probe. After 20 min (DPH) or 5 min (TMA-DPH) incubation
0.2 mg/ml for anisotropy measurements. The fluorescence anisotropies, r, were
-DPH). All anisotropy intensities were normalized to those (r°) observed before
, r°s of DPH and TMA-DPH were, respectively, 0.14±0.01 and 0.09±0.02; for
Fig. 8. Effects of increasing concentrations of JS023 on the fluorescence anisotropy
of TMA-DPH-labelled rat and mouse mitochondria. The experimental procedure
was the same as described in the legend to Fig. 6. All anisotropy intensities were
normalized to those (r°) observed before addition of JS023 (see legend to Fig. 6).
Data are means (±SD) of three independent determinations.
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by NRB and NRB analogues, we measured the fluorescence
anisotropy changes of DPH- and TMA-DPH-labelled mitochon-
dria (in the presence of CsA to prevent opening of the PTP). In
particular, we investigated whether the increase of PT-inducing
efficacy correlated with a change in the distribution pattern of the
drug in the membrane. We compared the effects of the whole
molecule with those of its active subunit, DR166, along with the
cationic derivative JS023, at 50 μM concentrations (Fig. 7). In rat
mitochondria (panel A), NRB mostly affected the hydrophobic
core of the lipid bilayer, as detected by the changes in DPH
anisotropy. The decline of anisotropy intensity is indicative of an
increase in lipid fluidity [11,17]. No relevant structural modifica-
tions of the polar heads/lipid backbone interface regions, as
monitored by TMA-DPH anisotropy [17], were apparent. These
data suggest a preferential accommodation of NRB in the interior
of the lipid bilayer. In contrast, DR166 (panel B)mostly perturbed
the lipid domains sensed by TMA-DPH, which suggests a
preferential accumulation of this fragment in the lipid tail/polar
heads border areas. Such lipid domains should mainly reside in
the matrix-exposed leaflet of the inner membrane bilayer since we
found that TMA-DPH is transported in the inner membrane
interior by charge effects (data not shown). Accumulation of the
cationic drug JS023 in the matrix-exposed regions caused a
relevant increase of TMA-DPH anisotropy (panel C), which
reflects a structural immobilization of these membrane domains,
probably due to ionic interactions between JS023 and the
negatively charged phospholipid heads. Similar effects were
observed with other cationic NRB analogues, such as OL14 and
DR380 (data not shown).
In mouse mitochondria (Fig. 7, panels A′, B′), DPH and
TMA-DPH reported only minor changes in the membrane
dynamic properties upon interaction with the neutral compounds,
NRB and DR166; on the other hand, the cationic analogue JS023
(panel C′) exhibited effects similar to those observed in rat
mitochondria. It is noteworthy that rat and mouse mitochondria
displayed a marked difference in TMA-DPH anisotropy changesat increasing concentrations of JS023 below 50 μM (Fig. 8). With
mouse mitochondria, higher concentrations of cationic drug were
necessary to induce increases of the probe anisotropy comparable
to those obtained in rat mitochondria. Strikingly, the dose-
dependent anisotropy trend closely matched that obtained for PT
induction (Fig. 8, compare with Fig. 6A).
4. Discussion
The mechanisms underlying the rat-selective vasoconstric-
tion effect and toxicity of NRB are still poorly understood.
Detailed studies of the individual stereoisomers of NRB
demonstrated that both drug-induced contractile activity and
lethality in rats are strongly modulated by the molecular
isomerism, only the endo configurations retaining the patholog-
ical effects elicited by the mixture [7]. These results indicate that
binding of NRB in vivo is stereospecific, thereby suggesting the
existence of a drug receptor uniquely expressed in the myocytes
of the rat peripheral vessels. Moreover, recent experiments on
the rat caudal artery with selected fragments of the parent
molecule demonstrated that groups at all three sites (C-7, C-5
and imide) must be retained for NRB-type vasoconstriction, the
“endo-type” isomerism not being sufficient to cause toxic effects
per se [14].
Intriguingly, NRB was recently shown to cause rat-selective
opening of the PTP in isolated mitochondria [11], suggesting that
in vivo mitochondrial dysfunction could be a potential physio-
logical pathway leading to death in rats. To test this hypothesis,
we evaluated the PT-inducing effects of rat-toxic (endo-isomersV,
Y,W) and non toxic (exo-isomers R,X, T) compounds on isolated
liver mitochondria. The results obtained from our experiments
show that both lethal and non lethal NRB isomers display
comparable stimulatory effects on the PT. Yet, all PTP-active
isomers maintained a strict species-selectivity for the rat.
Although a direct correlation between NRB-induced
mitochondrial dysfunction and lethal vasoconstriction is not
obvious from these data, the possibility of PTP being a cause
of toxicity in the rat cannot be totally dismissed. As a matter
of fact, rat-selective PTP opening in isolated mitochondria
suggests that NRB may specifically affect rat mitochondria
in vivo as well. Indeed, studies on mitochondria isolated
from liver of rats previously subjected to NRB stress showed
that mitochondria were damaged to some extent and that
energy-dependent reactions were impaired (10). Very impor-
tantly, all compounds lethal to rats are also PTP-active in
isolated mitochondria. Although we observed induction of
the PT in isolated mitochondria also by non-lethal NRB
isoforms, our findings indicate that transport may be a key
factor determining bioavailability to mitochondria in situ.
Thus, the possibility exists that the exo-isomers do not reach
mitochondria in the tissues that are critical for toxicity. An
alternative hypothesis is that mitochondrial damage could
play a role in NRB toxicity as a secondary, potentiating
event.
In order to test whether the whole NRB molecule is
necessary (as found for the vasoconstriction effect) or whether
a specific active core is sufficient to account for the NRB effects
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of various NRB analogues, probing the parent molecule's three
key structural features (substituents at C-5, C-7 and the imide
unit). Our results indicate that neither the group at C-5 nor the
imide group play a critical role in PT induction, whereas the
(phenylvinyl)pyridine subunit at C-7 remains active, being
sufficient for PTP activation. The possibility that this subunit is
the key element conferring toxicity to NRB molecule also
in vivo cannot be ruled out: actually, molecular integrity and
endo-type stereoisomerism could be necessary for properly
modulating the binding of NRB to its cell receptors, the whole
molecular scaffold then functioning as a vector for the active
feature responsible for the rat-unique effects. Clearly, further
studies are necessary in order to better understand the mode of
action and selectivity of NRB and the possible correlations
between the different pathological effects.
If the hypothesis of a direct link between NRB-induced
mitochondrial dysfunction and vasoconstriction is correct, a
plausible mechanistic explanation should take into account the
unique behaviour of the rat mitochondrial system towards the
drug. The selectivity of PTP opening in isolated mitochon-
dria, in fact, would suggest that the interaction mode of NRB
in rat mitochondria is different from that taking place in
mitochondria from other animal species in vivo as well. This
difference could be due to a different pore structure/target or
to a different modality of drug internalisation. To better
clarify this point, we used cationic derivatives of the drug
which were shown to enter mitochondria driven by the inside-
negative potential of the inner membrane. CRC experiments
demonstrated that cationic NRB analogues can activate the
PTP, provided that they bear the active core of the molecule,
i.e. the (phenylvinyl)pyridine subunit. Under these conditions,
mouse and guinea pig mitochondria are also affected by the
drug. These findings clearly indicate that: i) NRB as well as
NRB substructures are endowed with an intrinsic ability to
cross mitochondrial membranes in all animal species. This is
not unexpected as the lipid composition of the mitochondrial
membranes is similar between the different species, ii) NRB
target on the PTP is the same in all animal species since it
specifically recognizes the (phenylvinyl)pyridine moiety. The
need of higher drug concentrations for PT induction in mouse
and guinea pig mitochondria, as compared to rat mitochon-
dria, can be ascribed to a different distribution pattern of the
drug in rat and non-rat species, as it can be deduced from the
results of fluorescence anisotropy experiments.
The fluorescence anisotropy experiments, carried out with
selected reporters of different membrane domains, indicate
that the target of NRB action is localized on the matrix side
of the mitochondria, which is in agreement with a
preferential stimulation by NRB of the PTP-activating
capacity of the internal Ca2+ site, as previously suggested
[11]. Actually, the order of drug efficacy, NRB
bDR166bcationic NRB, correlates very well with a gradual
shift of drug distribution from the core of the lipid bilayer to
matrix-exposed mitochondrial domains (Fig. 7). Furthermore,
there is a strict correspondence between the extent of drug-
induced perturbation of matrix lipid domains and theefficiency of PTP-activation (compare Figs. 8 and 6). Similar
correlations between membrane-perturbing effects and PTP
triggering by cationic NRB derivatives can be observed in
mouse and guinea pig mitochondria, which again suggests
that the selectivity of NRB action on mitochondria does not
concern the target of the drug on the pore. Rather, the higher
doses of cationic drug necessary to induce perturbation of
the matrix domains and PT activation, together with the
inertness of neutral compounds, clearly indicate that NRB
does not easily gain access to the mitochondrial matrix in
any species other than the rat.
Taken together, these findings suggest that the amount of NRB
taken up by mitochondria via passive diffusion may not be
sufficient to perturb mitochondria and stimulate the PT. Thus, as
previously suggested [11], the occurrence of PTP activation
specifically in rats probably involves a transport system allowing
a deeper penetration of the drug in the inner membrane.
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